Key insider moves
A Form 4 filing with the Securities and Exchange Commission shows that Gentex Corp (NASDAQ:GNTX) General Counsel Ryan Scott P. sold 9,024 shares of common stock on February 17, 2026, at a per-share price of $24.7302. The filing lists the total value of that transaction as approximately $223,165.
The same filing records an additional disposal by Ryan Scott P. of 14,399 shares at $24.89 per share, with that sale totaling $358,391. Together, these two dispositions represent 23,423 shares transacted on the reported date.
New share awards recorded
Separately from the sales, Ryan Scott P. is shown as having acquired 36,782 shares of Gentex common stock. The filing specifies that 25,782 of those shares are performance-based awards, where the ultimate number of shares granted was contingent on long-term performance incentives. The remaining 11,000 shares are time-based awards that vest 100% three years from the grant award date.
Quarterly results and analyst response
In other company developments, Gentex reported fourth-quarter 2025 results in which earnings per share came in at $0.43, narrowly surpassing the consensus forecast of $0.42. That outcome is recorded as a 2.38% surprise on EPS. Revenue for the period totaled $644.4 million, below the anticipated $650.81 million, representing a 0.98% miss relative to expectations.
Following the release, UBS adjusted its price target for Gentex to $25.00 from $26.00 while retaining a Neutral rating on the shares. UBS characterized the fourth-quarter performance as "better than headline," citing an 8% EBIT beat, and noted that earnings per share met expectations after accounting for "some one-time headwinds."
Context and observable signals
The public filings document both active insider selling and a concurrent grant of shares subject to performance and time-based vesting conditions. The company’s quarterly figures produced a marginal EPS beat alongside a slight revenue shortfall, and an analyst moved to lower its price target while keeping a neutral stance. Those facts are visible in regulatory filings and the company’s reported results.
Summary of observable facts
- Form 4 shows Ryan Scott P. sold 9,024 shares at $24.7302 on February 17, 2026, valued at roughly $223,165.
- The filing also records a disposal of 14,399 shares at $24.89, totaling $358,391.
- Ryan Scott P. acquired 36,782 shares: 25,782 performance-based and 11,000 that vest 100% three years from grant date.
- Gentex reported Q4 2025 EPS of $0.43 versus a $0.42 forecast (2.38% surprise) and revenue of $644.4 million versus $650.81 million expected (0.98% miss).
- UBS lowered its price target to $25 from $26 and maintained a Neutral rating, noting results were "better than headline" with an 8% EBIT beat and citing "some one-time headwinds."